View Post

Mayo Clinic sees hope in breast cancer vaccine

In In The News by Barbara Jacoby

By: Kristin Bender From: fox32chicago.com (KTVU) – Treating breast cancer has long involved addressing two problems: eliminating cancer cells from the tumor and preventing the disease from returning. Experts say the key may be to stimulate and strengthen the body’s immune system to do both jobs. Researchers at the Mayo Clinic in Florida announced they are working on a new …

Kadcyla, an Antibody Drug Conjugate for Breast Cancer Treatment

In In The News by Barbara Jacoby

by: Sheena Gurai, PharmD Intern From: rxeconsult.com What are Antibody-Drug Conjugates? There is a new class of drugs that has significant potential to create breakthroughs in cancer treatment. This class is known as antibody-drug conjugates (ADCs), which simply refers to a drug that is attached to an antibody [see figure 1]. Antibodies are proteins that the immune system uses to …

Scientists propose a breast cancer drug for bladder cancer patients

In In The News by Barbara Jacoby

From: MedicalXpress.com Researchers at Mayo Clinic have found amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors. These findings suggest that administering trastuzumab to MPUC patients with HER2 amplification could improve outcomes, just …

CHMP recommends EU approval of Roche’s Subcutaneous Herceptin for HER2 positive breast cancer

In In The News by Barbara Jacoby

(Menafn – M2 PRESSWIRE via COMTEX) New injectable administration takes two to five minutes, rather than 30 to 90 minutes with the current intravenous form, potentially saving both healthcare resources and patients’ time Herceptin is a personalised medicine used to treat more than 80,000 HER2-positive breast cancer patients in Europe each year Roche (six:RO)(six:ROG)(otcqx:RHHBY) is pleased to announce that the …